Tauvid: New Alzheimer’s Focused PET Radiopharmaceutical

Tauvid: New Alzheimer’s Focused PET Radiopharmaceutical

Recently, the FDA provided approval for the use of two new PET radiopharmaceuticals, Cerianna and Tauvid. Cerianna is a molecular imaging agent indicated for use in PET imaging for the detection of estrogen receptor-positive lesions as an adjunct to biopsy in patients...
The Current Status of Alzheimer’s PET Imaging

The Current Status of Alzheimer’s PET Imaging

Alzheimer’s disease is the sixth leading cause of death in the United States. Around one in three American seniors die from Alzheimer’s or another dementia, making it a bigger killer than breast and prostate cancer combined. In fact, deaths from Alzheimer’s disease...